These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30825105)

  • 21. Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation.
    Bonner JA; Willey CD; Yang ES; Dobelbower MC; Sanford LL; Bright SJ; Buchsbaum DJ; Raisch KP
    Radiother Oncol; 2011 Oct; 101(1):183-9. PubMed ID: 21722984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of novel orthotopic nude mouse models for human small-cell lung cancer.
    Isobe T; Onn A; Morgensztern D; Jacoby JJ; Wu W; Shintani T; Itasaka S; Shibuya K; Koo PJ; O'Reilly MS; Herbst RS
    J Thorac Oncol; 2013 Feb; 8(2):140-6. PubMed ID: 23328546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.
    Némati F; Daniel C; Arvelo F; Legrier ME; Froget B; Livartowski A; Assayag F; Bourgeois Y; Poupon MF; Decaudin D
    Anticancer Drugs; 2010 Jan; 21(1):25-32. PubMed ID: 19823076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models.
    Morimura O; Minami T; Kijima T; Koyama S; Otsuka T; Kinehara Y; Osa A; Higashiguchi M; Miyake K; Nagatomo I; Hirata H; Iwahori K; Takimoto T; Takeda Y; Kida H; Kumanogoh A
    Biochem Biophys Res Commun; 2017 Jul; 488(4):596-602. PubMed ID: 28526406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer.
    Bryant JL; Gieling RG; Meredith SL; Allen TJ; Walker L; Telfer BA; Supuran CT; Williams KJ; White A
    Int J Cancer; 2018 Jan; 142(1):191-201. PubMed ID: 28905987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
    Allison Stewart C; Tong P; Cardnell RJ; Sen T; Li L; Gay CM; Masrorpour F; Fan Y; Bara RO; Feng Y; Ru Y; Fujimoto J; Kundu ST; Post LE; Yu K; Shen Y; Glisson BS; Wistuba I; Heymach JV; Gibbons DL; Wang J; Byers LA
    Oncotarget; 2017 Apr; 8(17):28575-28587. PubMed ID: 28212573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer.
    Xu S; Lam SK; Cheng PN; Ho JC
    Cancer Sci; 2018 Nov; 109(11):3471-3482. PubMed ID: 30155941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells.
    Fang C; Zhang J; Qi D; Fan X; Luo J; Liu L; Tan Q
    PLoS One; 2014; 9(12):e115204. PubMed ID: 25506932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with the Chk1 inhibitor Gö6976 enhances cisplatin cytotoxicity in SCLC cells.
    Thompson R; Meuth M; Woll P; Zhu Y; Danson S
    Int J Oncol; 2012 Jan; 40(1):194-202. PubMed ID: 21894433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioluminescence-based high-throughput screen identifies pharmacological agents that target neurotransmitter signaling in small cell lung carcinoma.
    Improgo MR; Johnson CW; Tapper AR; Gardner PD
    PLoS One; 2011; 6(9):e24132. PubMed ID: 21931655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of degradable niclosamide derivatives able to specially inhibit small cell lung cancer (SCLC).
    He X; Li M; Ye W; Zhou W
    Bioorg Chem; 2021 Feb; 107():104574. PubMed ID: 33383327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.
    Jahchan NS; Dudley JT; Mazur PK; Flores N; Yang D; Palmerton A; Zmoos AF; Vaka D; Tran KQ; Zhou M; Krasinska K; Riess JW; Neal JW; Khatri P; Park KS; Butte AJ; Sage J
    Cancer Discov; 2013 Dec; 3(12):1364-77. PubMed ID: 24078773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
    Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
    Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic effects of pyrrolidine dithiocarbamate in small-cell lung cancer cells, alone and in combination with cisplatin.
    Tahata S; Yuan B; Kikuchi H; Takagi N; Hirano T; Toyoda H
    Int J Oncol; 2014 Oct; 45(4):1749-59. PubMed ID: 25070243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Soft Coral-Derived Compound, 11-Dehydrosinulariolide, Induces G2/M Cell Cycle Arrest and Apoptosis in Small Cell Lung Cancer.
    Lin YC; Su JH; Lin SC; Chang CC; Hsia TC; Tung YT; Lin CC
    Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30513611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis.
    Shi MX; Ding X; Tang L; Cao WJ; Su B; Zhang J
    BMC Cancer; 2024 Apr; 24(1):504. PubMed ID: 38644473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair.
    Solta A; Boettiger K; Kovács I; Lang C; Megyesfalvi Z; Ferk F; Mišík M; Hoetzenecker K; Aigner C; Kowol CR; Knasmueller S; Grusch M; Szeitz B; Rezeli M; Dome B; Schelch K
    Clin Cancer Res; 2023 Nov; 29(22):4644-4659. PubMed ID: 37725585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium chloride (NaCl) potentiates digoxin-induced anti-tumor activity in small cell lung cancer.
    Deng K; Shen J; Wang W; Li M; Li H; Chen C; Zhao H; Zhang M; Xue T; Liu Q; Lui VWY; Hong B; Lin W
    Cancer Biol Ther; 2019; 20(1):52-64. PubMed ID: 30183476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seed Oil of Brucea javanicaInduces Cell Cycle Arrest and Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction in Human Lung Cancer Cells.
    Wang D; Qu X; Zhuang X; Geng G; Hou J; Xu N; Li W; Hu T; Chen YS
    Nutr Cancer; 2016; 68(8):1394-1403. PubMed ID: 27635476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models.
    Baker AF; Hanke NT; Sands BJ; Carbajal L; Anderl JL; Garland LL
    J Exp Clin Cancer Res; 2014 Dec; 33(1):111. PubMed ID: 25612802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.